cell clearance determined by the H-2 phenotype of the target. J Exp Med 174: 327–334. 10. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H- 2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675–678. 11. Ljunggren HG, Karre K (1990) In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 11: 237–244. 12. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL (1993) HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A 90: 12000–12004. 13. Long EO (2008) Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 224: 70–84. 14. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, et al. (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4: 77–85. 15. Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, et al. (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T- cell contacts. Cell 94: 667–677. 16. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, et al. (1999) The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221–227. 17. Davis DM, Chiu I, Fassett M, Cohen GB, Mandelboim O, et al. (1999) The human natural killer cell immune synapse. Proc Natl Acad Sci U S A 96: 15062–15067. 18. Batista FD, Iber D, Neuberger MS (2001) B cells acquire antigen from target cells after synapse formation. Nature 411: 489–494. 19. Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, et al. (2001) Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol 167: 4358–4367. 20. Davis DM, Dustin ML (2004) What is the importance of the immunological synapse? Trends Immunol 25: 323–327. 21. Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425–434. 22. Davis SJ, van der Merwe PA (1996) The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today 17: 177–187. 23. Davis SJ, van der Merwe PA (2006) The kinetic-segregation model: TCR triggering and beyond. Nat Immunol 7: 803–809. 24. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A (1998) Three- dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82–86. 25. van der Merwe PA, Davis SJ, Shaw AS, Dustin ML (2000) Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin Immunol 12: 5–21. 26. Bunnell SC, Hong DI, Kardon JR, Yamazaki T, McGlade CJ, et al. (2002) T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J Cell Biol 158: 1263–1275. 27. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML (2006) T cell receptor- proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25: 117–127. 28. Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, et al. (2003) CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nat Immunol 4: 189–197. 29. Lin J, Weiss A (2003) The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling. J Cell Biol 162: 673–682. 30. Choudhuri K, Wiseman D, Brown MH, Gould K, van der Merwe PA (2005) T- cell receptor triggering is critically dependent on the dimensions of its peptide- MHC ligand. Nature 436: 578–582. 31. Choudhuri K, Parker M, Milicic A, Cole DK, Shaw MK, et al. (2009) Peptide- major histocompatibility complex dimensions control proximal kinase-phospha- tase balance during T cell activation. Journal of Biological Chemistry 284: 26096–26105. 32. Bryceson YT, Long EO (2008) Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 20: 344–352. 33. McCann FE, Vanherberghen B, Eleme K, Carlin LM, Newsam RJ, et al. (2003) The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J Immunol 170: 2862–2870. 34. Fan QR, Long EO, Wiley DC (2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2: 452–460. 35. Li P, Morris DL, Willcox BE, Steinle A, Spies T, et al. (2001) Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2: 443–451. 36. Staunton DE, Dustin ML, Erickson HP, Springer TA (1990) The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 61: 243–254. Ligand Size Is Important for NK Signal Integration 37. Almeida CR, Davis DM (2006) Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density. J Immunol 177: 6904–6910. 38. Orange JS (2008) Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol 8: 713–725. 39. Hidano S, Sasanuma H, Ohshima K, Seino K, Kumar L, et al. (2008) Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN- gamma production. Int Immunol 20: 345–352. 40. Chuang SS, Kim MH, Johnson LA, Albertsson P, Kitson RP, et al. (2000) 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology 100: 378–383. 41. Chen X, Allan DS, Krzewski K, Ge B, Kopcow H, et al. (2006) CD28- stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc Natl Acad Sci U S A 103: 10346–10351. 42. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661–671. 43. Yu YY, Netuschil N, Lybarger L, Connolly JM, Hansen TH (2002) Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 168: 3145–3149. 44. Shimizu Y, DeMars R (1989) Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C human cell line. J Immunol 142: 3320–3328. 45. Davis DM (2009) Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol 9: 543–555. 46. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, et al. (1997) The Leukocyte Antigen Factsbook: Academic Press. 47. Brzostek J, Chai JG, Gebhardt F, Busch DH, Zhao R, et al. (2010) Ligand dimensions are important in controlling NK-cell responses. Eur J Immunol 40: 2050–2059. 48. Rajagopalan S, Long EO (1997) The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. Journal of Experimental Medicine 185: 1523–1528. 49. Mandelboim O, Wilson SB, Vales-Gomez M, Reyburn HT, Strominger JL (1997) Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A 94: 4604–4609. 50. Standeven LJ, Carlin LM, Borszcz P, Davis DM, Burshtyn DN (2004) The actin cytoskeleton controls the efficiency of killer Ig-like receptor accumulation at inhibitory NK cell immune synapses. J Immunol 173: 5617–5625. 51. Faure M, Barber DF, Takahashi SM, Jin T, Long EO (2003) Spontaneous clustering and tyrosine phosphorylation of NK cell inhibitory receptor induced by ligand binding. J Immunol 170: 6107–6114. 52. Culley FJ, Johnson M, Evans JH, Kumar S, Crilly R, et al. (2009) Natural killer cell signal integration balances synapse symmetry and migration. PLoS Biol 7: e1000159. 53. Willcox BE, Thomas LM, Bjorkman PJ (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 4: 913–919. 54. Sharma D, Bastard K, Guethlein LA, Norman PJ, Yawata N, et al. (2009) Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol 183: 4569–4582. 55. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R (1988) Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompat- ibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A 85: 227–231. 56. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, et al. (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24: 406–415. 57. Carlin LM, Eleme K, McCann FE, Davis DM (2001) Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J Exp Med 194: 1507–1517. 58. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22: 1567–1572. 59. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, et al. (1998) 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 188: 2083–2090. 60. Burshtyn DN, Shin J, Stebbins C, Long EO (2000) Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Current Biology 10: 777–780. 61. Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15–22. PLoS ONE | www.plosone.org 11 November 2010 | Volume 5 | Issue 11 | e15374